Windham Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-15,301
| Closed | -$2.08M | – | 52 |
|
|
2023
Q4 | $2.08M | Buy |
15,301
+33
| +0.2% | +$4.48K | 0.77% | 36 |
|
|
2023
Q3 | $1.87M | Hold |
15,268
| – | – | 0.75% | 36 |
|
|
2023
Q2 | $1.94M | Hold |
15,268
| – | – | 0.75% | 37 |
|
|
2023
Q1 | $1.97M | Buy |
15,268
+568
| +4% | +$73.4K | 0.78% | 37 |
|
|
2022
Q4 | $1.93M | Hold |
14,700
| – | – | 0.74% | 33 |
|
|
2022
Q3 | $1.72M | Hold |
14,700
| – | – | 0.65% | 36 |
|
|
2022
Q2 | $1.73M | Hold |
14,700
| – | – | 0.41% | 36 |
|
|
2022
Q1 | $1.92M | Hold |
14,700
| – | – | 0.41% | 36 |
|
|
2021
Q4 | $2.24M | Hold |
14,700
| – | – | 0.46% | 34 |
|
|
2021
Q3 | $2.38M | Hold |
14,700
| – | – | 0.5% | 31 |
|
|
2021
Q2 | $2.41M | Hold |
14,700
| – | – | 0.49% | 30 |
|
|
2021
Q1 | $2.21M | Hold |
14,700
| – | – | 0.47% | 31 |
|
|
2020
Q4 | $2.23M | Hold |
14,700
| – | – | 0.48% | 28 |
|
|
2020
Q3 | $1.99M | Hold |
14,700
| – | – | 0.44% | 28 |
|
|
2020
Q2 | $2.01M | Hold |
14,700
| – | – | 0.46% | 26 |
|
|
2020
Q1 | $1.58M | Hold |
14,700
| – | – | 0.38% | 28 |
|
|
2019
Q4 | $1.77M | Hold |
14,700
| – | – | 0.38% | 38 |
|
|
2019
Q3 | $1.46M | Hold |
14,700
| – | – | 0.33% | 34 |
|
|
2019
Q2 | $1.6M | Hold |
14,700
| – | – | 0.27% | 30 |
|
|
2019
Q1 | $1.64M | Buy |
+14,700
| New | +$1.64M | 0.28% | 30 |
|